Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.